Screening, Brief Intervention, Referral to Treatment (SBIRT)

This inaugural National Strategy proposes bold, targeted, and consequential actions to bend the curve on overdose deaths in the immediate term and reduce substance use and its damaging consequences in the US over the longer term.

These guidelines contain recommendations on the identification and management of substance use and substance use disorders for health care services which assist women who are pregnant, or have recently had a child, and who use alcohol or drugs or who have a substance use disorder.

This brief describes the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model for pregnant and postpartum women with substance use disorders and how to implement and integrate SBIRT into care delivery.

This report aims to address the treatment opportunities for pregnant and postpartum (or parenting) women (PPW) with substance use disorder (SUD) by describing opportunities to integrate obstetricians and gynecologists (OB/GYN) and SUD care as well as barriers to integrated care delivery.

In this webinar, Drs. John Iskander and Suzanne Gilboa discuss what CDC and its partners are doing to reduce prenatal substance exposure and how screening and brief interventions may reduce prenatal substance exposure and improve the health of women and infants.

This screening device is often used as a way to begin discussion about drug and alcohol use. Any woman who answers yes to one or more questions should be referred for further assessment.

This guide will explans how to choose a screening tool for Perinatal Mood and Anxiety Disorders (PMADs), provides recommendations and resources on how to administer the tools, recommends additional screening tools, presents an algorithm and response protocol, and briefly touches on establishing outside resources and referrals.

This toolkit provides tools to both providers and patients for the assessment and management of perinatal mood and anxiety disorders, as well as substance use disorders (SUD).